Graf Akcie CBAY (Cymabay Therapeutics Inc). Diskuze k akciím CBAY. Aktuální informace CBAY.

Základní informace o společnosti Cymabay Therapeutics Inc (Akcie CBAY)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace	282.88M
Hodnota podniku (EV)	N/A
Tržby	0.00
EBITDA	N/A
Zisk	-67.95
Růst v tržbách Q/Q	N/A %
Růst v tržbách Y/Y	N/A %
P/E (Cena vůči ziskům)	0.00
Forward P/E	-26.16
EV/Sales	N/A
EV/EBITDA	N/A
EV/EBIT	N/A
PEG	N/A
Price/Sales	N/A
P/FCF	N/A
Price/Book	1.98
Účetní hodnota na akcii	2.05
Hotovost na akcii	2.10
FCF vůči ceně	-21.97 %
Počet zaměstnanců	44
Tržba na zaměstnance	0.00
Profit margin	N/A %
Operating margin	N/A %
Gross margin	N/A %
EBIT margin	N/A %
EBITDA margin	N/A %

EPS - Zisk na akcii	N/A
EPS - Kvartální růst	112.50 %
EPS - Očekávaný růst příští rok	52.94 %
Return on assets	-47.18 %
Return on equity	-50.89 %
ROIC	-28.36 %
ROCE	-62.86 %
Dluhy/Equity	0.08
Čistý dluh/EBITDA	6.76
Current ratio	12.70
Quick Ratio	12.70
Volatilita	4.66
Beta	0.75
RSI	56.55
Cílová cena analytiků	13
Známka akcie (dle analytiků)	1.00
Insider ownership	0.40 %
Institutional ownership	82.69 %
Počet akcií	68.998M
Procento shortovaných akcií	4.47 %
Short ratio	7.20 %
Dividenda	N/A
Procentuální dividenda	N/A %
Dividenda/Zisk	N/A %
Obchodovaná od	2014
Země	United States

Finanční výsledky akcie CBAY

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

#	2020	2019	2018	2017	2016	2015
Revenue	-	-	$10	-	-	-	-	$3.05
Cost Of Goods Sold	-	-	-	-	-	-	-	-
Gross Profit	-	-	$10	-	-	-	-	$3.05
Research And Development Expenses	$83.837	$58.124	$18.938	$15.941	$17.026	$15.823	$4.525	$9.28
SG&A Expenses	$19.238	$14.381	$12.387	$9.645	$8.871	$8.185	$4.871	$4.208
Other Operating Income Or Expenses	-	-	-	-	-	-	-	-
Operating Expenses	$108.15	$72.505	$31.325	$25.586	$25.897	$24.008	$9.396	$13.488
Operating Income	$-108.15	$-72.505	$-21.325	$-25.586	$-25.897	$-24.008	$-9.396	$-10.438
Total Non-Operating Income/Expense	$5.342	$-0.043	$-6.232	$-1.085	$10.368	$-7.909	$-0.677	$-0.817
Pre-Tax Income	$-102.808	$-72.548	$-27.557	$-26.671	$-15.529	$-31.917	$-10.073	$-11.255
Income Taxes	-	-	-	-	-	-	-	-
Income After Taxes	$-102.808	$-72.548	$-27.557	$-26.671	$-15.529	$-31.917	$-10.073	$-11.255
Other Income	-	-	-	-	-	-	-	-
Income From Continuous Operations	$-102.808	$-72.548	$-27.557	$-26.671	$-15.529	$-31.917	$-10.073	$-11.255
Income From Discontinued Operations	-	-	-	-	-	-	-	-
Net Income	$-102.808	$-72.548	$-27.557	$-26.671	$-15.529	$-31.917	$243.994	$-23.899
EBITDA	$-109.815	$-74.345	$-21.489	$-25.432	$-25.364	$-23.537	$-9.283	$-10.319
EBIT	$-108.15	$-72.505	$-21.325	$-25.586	$-25.897	$-24.008	$-9.396	$-10.438
Basic Shares Outstanding	67	58	35	23	19	12	2	0
Shares Outstanding	67	58	35	23	19	12	3	0
Basic EPS	$-1.53	$-1.25	$-0.79	$-1.14	$-0.82	$-2.65	$103.52	$-4128.71
EPS - Earnings Per Share	$-1.53	$-1.26	$-0.79	$-1.14	$-0.83	$-2.65	$-3.54	$-4128.71

#	2020	2019	2018	2017	2016	2015
Cash On Hand	$190.945	$178.664	$97.21	$16.994	$41.48	$34.795
Receivables	$0.687	$0.304	$5	-	-	$0.347
Inventory	-	-	-	-	-	-
Pre-Paid Expenses	$11.291	$2.594	$1.208	$1.369	$0.608	$1.991
Other Current Assets	-	-	$0.126	$0.165	$0.186	$0.096
Total Current Assets	$202.923	$181.562	$103.544	$18.528	$42.274	$37.229
Property, Plant, And Equipment	$2.409	$2.905	$0.069	$0.077	$0.064	$0.086
Long-Term Investments	-	-	-	-	-	-
Goodwill And Intangible Assets	-	-	-	-	-	-
Other Long-Term Assets	$0.16	$2.28	$0.634	$0.754	$0.741	$0.159
Total Long-Term Assets	$2.804	$5.185	$0.703	$0.831	$0.805	$0.245
Total Assets	$205.727	$186.747	$104.247	$19.359	$43.079	$37.474
Total Current Liabilities	$17.636	$14.415	$16.31	$9.311	$6.146	$20.459
Long Term Debt	-	-	$2.99	$6.098	$8.799	$3.152
Other Non-Current Liabilities	-	$1.914	-	$0.013	$0.019	$0.013
Total Long Term Liabilities	$1.743	$1.914	$2.99	$6.111	$8.818	$3.165
Total Liabilities	$19.379	$16.329	$19.3	$15.422	$14.964	$23.624
Common Stock Net	$0.007	$0.006	$0.004	$0.002	$0.002	$0.001
Retained Earnings (Accumulated Deficit)	$-625.872	$-523.064	$-450.516	$-422.959	$-396.288	$-380.759
Comprehensive Income	$0.08	$-0.058	$-0.044	$-0.001	$-0.021	$-0.014
Other Share Holders Equity	-	-	-	-	-	-
Share Holder Equity	$186.348	$170.418	$84.947	$3.937	$28.115	$13.85
Total Liabilities And Share Holders Equity	$205.727	$186.747	$104.247	$19.359	$43.079	$37.474

#	2020	2019	2018	2017	2016	2015
Net Income/Loss	$-102.808	$-72.548	$-27.557	$-26.671	$-15.529	$-31.917
Total Depreciation And Amortization - Cash Flow	$-1.665	$-1.84	$-0.164	$0.154	$0.533	$0.471
Other Non-Cash Items	$10.468	$10.593	$11.13	$2.874	$-8.406	$8.728
Total Non-Cash Items	$8.803	$8.753	$10.966	$3.028	$-7.873	$9.199
Change In Accounts Receivable	-	$5	$-5	-	-	$-0.101
Change In Inventories	-	-	-	-	-	-
Change In Accounts Payable	$0.53	$0.662	$0.412	$-0.109	$-1.077	$1.388
Change In Assets/Liabilities	$-6.96	$-3.253	$0.16	$-0.616	$1.201	$-1.572
Total Change In Assets/Liabilities	$-3.906	$8.859	$-3.041	$0.29	$0.078	$1.604
Cash Flow From Operating Activities	$-97.911	$-54.936	$-19.632	$-23.353	$-23.324	$-21.114
Net Change In Property, Plant, And Equipment	$-0.315	$-0.529	$-0.027	$-0.042	-	$-0.103
Net Change In Intangible Assets	-	-	-	-	-	-
Net Acquisitions/Divestitures	-	-	-	-	-	-
Net Change In Short-term Investments	$-34.032	$-53.582	$-67.501	$27.17	$-11.083	$-16.835
Net Change In Long-Term Investments	-	-	-	-	-	-
Net Change In Investments - Total	$-34.032	$-53.582	$-67.501	$27.17	$-11.083	$-16.835
Investing Activities - Other	-	-	-	-	-	-
Cash Flow From Investing Activities	$-34.347	$-54.111	$-67.528	$27.128	$-11.083	$-16.938
Net Long-Term Debt	-	$-6.653	$-3.137	$-0.986	$4.726	$-0.244
Net Current Debt	-	-	-	-	-	-
Debt Issuance/Retirement Net - Total	-	$-6.653	$-3.137	$-0.986	$4.726	$-0.244
Net Common Equity Issued/Repurchased	$108.132	$141.641	$102.856	-	$25.801	$25.481
Net Total Equity Issued/Repurchased	$108.132	$141.641	$102.856	-	$25.801	$25.481
Total Common And Preferred Stock Dividends Paid	-	-	-	-	-	-
Financial Activities - Other	-	-	-	-	-	-
Cash Flow From Financial Activities	$108.132	$134.988	$99.719	$-0.986	$30.527	$25.237
Net Cash Flow	$-24.126	$25.941	$12.559	$2.789	$-3.88	$-12.815
Stock-Based Compensation	$10.468	$7.013	$4.92	$2.473	$2.487	$1.292
Common Stock Dividends Paid	-	-	-	-	-	-

#	2020	2019	2018	2017	2016	2015
Current Ratio	11.5062	12.5954	6.3485	1.9899	6.8783	1.8197
Long-term Debt / Capital	-	-	0.034	0.6077	0.2384	0.1854
Debt/Equity Ratio	-	-	0.0718	2.2347	0.3311	0.3254
Gross Margin	-	-	100	-	-	-
Operating Margin	-	-	-213.25	-	-	-
EBIT Margin	-	-	-213.25	-	-	-
EBITDA Margin	-	-	-214.89	-	-	-
Pre-Tax Profit Margin	-	-	-275.57	-	-	-
Net Profit Margin	-	-	-275.57	-	-	-
Asset Turnover	-	-	0.0959	-	-	-
Inventory Turnover Ratio	-	-	-	-	-	-
Receiveable Turnover	-	-	2	-	-	-
Days Sales In Receivables	-	-	182.5	-	-	-
ROE - Return On Equity	-55.1699	-42.5706	-32.4402	-677.4468	-55.2338	-230.4474
Return On Tangible Equity	-55.1699	-42.5706	-32.4402	-677.4449	-55.2339	-230.4477
ROA - Return On Assets	-49.973	-38.8483	-26.4343	-137.7706	-36.0477	-85.1711
ROI - Return On Investment	-55.1699	-42.5706	-31.3372	-265.7798	-42.0681	-187.725
Book Value Per Share	2.7053	2.8663	1.9128	0.1679	1.1991	0.9424
Operating Cash Flow Per Share	-0.5108	-0.3873	0.4335	0.237	0.5193	1.2196
Free Cash Flow Per Share	-0.5063	-0.3958	0.4346	0.2352	0.5279	0.9798

Warning: Undefined array key "user" in /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/views/stock.php on line 716

Fatal error: Uncaught mysqli_sql_exception: You have an error in your SQL syntax; check the manual that corresponds to your MariaDB server version for the right syntax to use near 'AND valid >= CURDATE()' at line 2 in /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/php/classes/Database.php:11 Stack trace: #0 /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/php/classes/Database.php(11): mysqli_query(Object(mysqli), 'SELECT * FROM p...') #1 /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/views/stock.php(716): Database::Execute(Object(mysqli), 'SELECT * FROM p...') #2 /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/routes.php(20): require_once('/data/web/virtu...') #3 /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/php/classes/Route.php(8): {closure}() #4 /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/php/classes/Route.php(8): Closure->__invoke() #5 /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/routes.php(21): Route::set('graf-akcie/CBAY', Object(Closure)) #6 /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/index.php(23): require_once('/data/web/virtu...') #7 {main} thrown in /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/php/classes/Database.php on line 11

JenAkcie

Graf Akcie CBAY (Cymabay Therapeutics Inc). Diskuze k akciím CBAY. Aktuální informace CBAY.

Základní informace o společnosti Cymabay Therapeutics Inc (Akcie CBAY)

Finanční výsledky akcie CBAY